Neuropharmacology plays a critical role in understanding and treating mental health disorders, from depression and anxiety to schizophrenia and bipolar disorder. This book explores the pharmacological mechanisms underlying these conditions, focusing on current therapies and emerging drug targets. It emphasizes the integration of neurobiology, pharmacology, and clinical practice, offering insights for researchers, psychiatrists, and healthcare providers addressing mental health challenges.
Emma Palmer is an expert dermatologist specializing in neuropharmacology and its implications for mental health disorders related to skin conditions. Her research investigates how neuropharmacological agents can influence both mental health and dermatological outcomes, exploring the bidirectional relationship between the nervous system and skin health. Emma has authored numerous studies on the use of neuroactive drugs in managing conditions such as psoriasis, eczema, and acne, which are often associated with mental health challenges. She has developed comprehensive treatment protocols that integrate neuropharmacological approaches with dermatological care.